Cutler Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-20,500
| Closed | -$20K | – | 2366 |
|
|
2023
Q4 | $20K | Buy |
20,500
+15,500
| +310% | +$814K | ﹤0.01% | 1969 |
|
|
2023
Q3 | $39K | Sell |
5,000
-200
| -4% | -$12.3K | ﹤0.01% | 1639 |
|
|
2023
Q2 | $1K | Sell |
5,200
-8,200
| -61% | -$550K | ﹤0.01% | 3202 |
|
|
2023
Q1 | $44K | Sell |
13,400
-53,100
| -80% | -$3.75M | ﹤0.01% | 1427 |
|
|
2022
Q4 | $166K | Buy |
66,500
+25,500
| +62% | +$1.92M | 0.01% | 879 |
|
|
2022
Q3 | $64K | Sell |
41,000
-2,800
| -6% | -$203K | ﹤0.01% | 1722 |
|
|
2022
Q2 | $48K | Sell |
43,800
-87,200
| -67% | -$6.64M | ﹤0.01% | 1967 |
|
|
2022
Q1 | $46K | Buy |
131,000
+41,200
| +46% | +$2.77M | ﹤0.01% | 2307 |
|
|
2021
Q4 | $214K | Sell |
89,800
-3,600
| -4% | -$211K | 0.01% | 1263 |
|
|
2021
Q3 | $483K | Buy |
93,400
+30,100
| +48% | +$1.98M | 0.02% | 811 |
|
|
2021
Q2 | $207K | Sell |
63,300
-15,500
| -20% | -$1.01M | 0.01% | 1316 |
|
|
2021
Q1 | $210K | Sell |
78,800
-24,800
| -24% | -$1.54M | 0.01% | 1234 |
|
|
2020
Q4 | $364K | Sell |
103,600
-2,600
| -2% | -$160K | 0.02% | 779 |
|
|
2020
Q3 | $572K | Sell |
106,200
-133,200
| -56% | -$8.02M | 0.04% | 491 |
|
|
2020
Q2 | $990K | Sell |
239,400
-80,300
| -25% | -$4.8M | 0.07% | 291 |
|
|
2020
Q1 | $1.6M | Sell |
319,700
-529,900
| -62% | -$32.4M | 0.08% | 235 |
|
|
2019
Q4 | $655K | Buy |
849,600
+813,400
| +2,247% | +$46.6M | 0.04% | 362 |
|
|
2019
Q3 | $41K | Buy |
36,200
+10,100
| +39% | +$475K | ﹤0.01% | 1682 |
|
|
2019
Q2 | $82K | Sell |
26,100
-449,400
| -95% | -$20.9M | 0.01% | 1209 |
|
|
2019
Q1 | $439K | Buy |
475,500
+433,800
| +1,040% | +$21.6M | 0.05% | 357 |
|
|
2018
Q4 | $65K | Buy |
41,700
+4,000
| +11% | +$215K | 0.01% | 1322 |
|
|
2018
Q3 | $11K | Hold |
37,700
| – | – | ﹤0.01% | 2582 |
|
|
2018
Q2 | $57K | Sell |
37,700
-47,700
| -56% | -$2.58M | ﹤0.01% | 1517 |
|
|
2018
Q1 | $56K | Sell |
85,400
-9,500
| -10% | -$611K | ﹤0.01% | 1578 |
|
|
2017
Q4 | $79K | Sell |
94,900
-5,300
| -5% | -$332K | ﹤0.01% | 1529 |
|
|
2017
Q3 | $93K | Buy |
100,200
+71,100
| +244% | +$4.15M | ﹤0.01% | 1718 |
|
|
2017
Q2 | $53K | Sell |
29,100
-83,100
| -74% | -$4.52M | ﹤0.01% | 2429 |
|
|
2017
Q1 | $157K | Buy |
112,200
+96,400
| +610% | +$5.29M | 0.01% | 1372 |
|
|
2016
Q4 | $124K | Sell |
15,800
-2,300
| -13% | -$126K | ﹤0.01% | 1712 |
|
|
2016
Q3 | $215K | Buy |
+18,100
| New | +$1.16M | 0.01% | 1149 |
|
Other funds holding BMY
Cutler Group's BMY Position: Q1 2024 in Review
Cutler Group reduced its Bristol-Myers Squibb (BMY) stake by 76% in Q1 2024, selling an estimated $620K and leaving 3,811 shares worth $206K. The position accounts for 0.07% of the portfolio, ranked #277.
Cutler Group first reported a position in BMY in Q4 2015 and has held it in 33 quarters since. The position peaked at $10.2M in Q4 2019. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- Cutler Group held 3,811 shares of Bristol-Myers Squibb worth $206K as of Q1 2024.
- Cutler Group sold 12,173 Bristol-Myers Squibb shares in Q1 2024, an estimated $620K.
- Bristol-Myers Squibb made up 0.07% of Cutler Group's portfolio in Q1 2024, its #277 holding.
- Cutler Group first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 33 quarters since.
- Cutler Group's Bristol-Myers Squibb position peaked at $10.2M in Q4 2019.
- 2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.